Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | opioid receptor, kappa 1 | References | |
Homo sapiens | guanylate cyclase 1, soluble, alpha 2 | References | |
Homo sapiens | guanylate cyclase 1, soluble, alpha 3 | References | |
Homo sapiens | guanylate cyclase 1, soluble, beta 3 | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | Soluble guanylate cyclase 88E, putative | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Onchocerca volvulus | Get druggable targets OG5_128451 | All targets in OG5_128451 | |
Schistosoma mansoni | soluble guanylate cyclase gcy | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Loa Loa (eye worm) | guanylyl cyclase/natriuretic peptide receptor | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Brugia malayi | Adenylate and Guanylate cyclase catalytic domain containing protein | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Schistosoma japonicum | Soluble guanylate cyclase gcy-33, putative | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_128451 | All targets in OG5_128451 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | soluble guanylate cyclase gcy | guanylate cyclase 1, soluble, beta 3 | 619 aa | 633 aa | 29.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | atrial natriuretic peptide receptor 1 | 0.0058 | 0 | 0.5 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.017 | 0.8293 | 0.8293 |
Loa Loa (eye worm) | guanylyl cyclase/natriuretic peptide receptor | 0.0193 | 1 | 1 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.0193 | 1 | 1 |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.017 | 0.8293 | 0.8293 |
Loa Loa (eye worm) | hypothetical protein | 0.0193 | 1 | 1 |
Schistosoma mansoni | soluble guanylyl cyclase beta-3 | 0.0161 | 0.7627 | 0.7627 |
Onchocerca volvulus | 0.0193 | 1 | 0.5 | |
Schistosoma mansoni | soluble guanylate cyclase gcy | 0.017 | 0.8293 | 0.8293 |
Schistosoma mansoni | hypothetical protein | 0.0161 | 0.7627 | 0.7627 |
Echinococcus granulosus | atrial natriuretic peptide receptor 1 | 0.0058 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 240 nM | Activation of SGC in HEK293 cells assessed as cGMP production after 20 mins by LC-MS/MS analysis in presence of NO-donor DETA-NONOate | ChEMBL. | 27190594 |
EC50 (binding) | = 1.5 uM | Agonist activity at KOP receptor (unknown origin) | ChEMBL. | 27190594 |
IC50 (binding) | = 1.2 uM | Binding affinity to KOP receptor (unknown origin) at 10 uM | ChEMBL. | 27190594 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.